Home › Cardiovascular Disease › Georgia › Johns Creek
Cardiovascular Disease clinical trials in Johns Creek, GA
3 studies for Cardiovascular Disease are looking for participants at sites in and around Johns Creek (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- NSC Research Inc, Johns Creek
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Johns Creek
- Clinical Trial Site, Suwanee · 7 mi away
- Clinical Trial Site, Lawrenceville · 13 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Nsc Research, Johns Creek
- Northeast Georgia Medical Center Wisteria Building, Cumming · 13 mi away
- Georgia Clinical Research, Lawrenceville · 13 mi away
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Johns Creek
- Obesity16 studies
- Overweight14 studies
- Schizophrenia8 studies
- Type 2 Diabetes8 studies
- Major Depressive Disorder7 studies
- Lung Cancer6 studies
- Heart Failure5 studies
- Non-Small Cell Lung Cancer5 studies
- High Blood Pressure4 studies
- Breast Cancer4 studies
- Atrial Fibrillation4 studies
- Chronic Kidney Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.